Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
US-2017208803-A1 · Jul 27, 2017 · US
US10072282B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10072282-B2 |
| Application number | US-201615002790-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 21, 2016 |
| Priority date | Dec 22, 2010 |
| Publication date | Sep 11, 2018 |
| Grant date | Sep 11, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Method for identifying a modulator of Sirt6, PfSir2a, or Sirt7 deacylase activity, wherein a fatty-acylated substrate containing an acyl-lysine moiety and an indicator moiety is contacted with Sirt6, PfSir2a, or Sirt7 in the presence of a candidate compound under conditions for Sirt6, PfSir2a, or Sirt7 to deacylate the substrate, wherein the acyl is a hydrophobic fatty acyl group containing a hydrocarbon group having at least three carbon atoms connected by carbon-carbon bonds; contacting the deacylated substrate with a cleavage agent that cleaves the linkage between the lysine and indicator moiety to generate a detectable signal; and correlating a quantified Sirt6, PfSir2a, or Sirt7 deacylase activity therefrom. Modulating compounds of Sirt6, PfSir2a, or Sirt7 deacylase activity are also described, as are pharmaceutical compositions thereof, methods of treatment by administration of the modulating compounds, and kits for practicing the method.
Opening claim text (preview).
What is claimed is: 1. A method for identifying an inhibitor of Sirt6, PfSir2a, or Sirt7 deacylase activity, the method comprising: (i) contacting an acylated substrate with Sirt6, PfSir2a, or Sirt7 in the presence of a candidate compound and in the presence of nicotinamide adenine dinucleotide (NAD) under conditions for Sirt6, PfSir2a, or Sirt7 to deacylate the substrate to provide a deacylated substrate, wherein said acylated substrate has the following chemical structure: wherein R 7 is a hydrocarbon group having at least three carbon atoms connected by carbon-carbon bonds, wherein said hydrocarbon group optionally includes one heteroatom selected from O, N, and S that interrupts a carbon-carbon bond of said hydrocarbon group or replaces a carbon atom of said hydrocarbon group, except that said heteroatom is not included as an OH, SH, or NH 2 group, and wherein one or more hydrogen atoms in said hydrocarbon group is optionally replaced with fluoro atoms; R 8 is selected from S, NR 13 , and O, wherein R 13 is a hydrogen atom or a hydrocarbon group R; X 4 , X 5 , and X 6 are independently selected from —(CH 2 ) n —, —NR 14 —, —O—, —S—, or a bond, wherein R 14 is a hydrogen atom or a hydrocarbon group R, and wherein n represents 1, 2, or 3; R 11 is a hydrogen atom or a hydrocarbon group R; R 9 and R 10 are independently hydrogen atom or a hydrocarbon group R, wherein R 10 can alternatively be OH or SH, and wherein at least one of R 9 and R 10 is a fluorophore; wherein said hydrocarbon groups R are independently either unsubstituted, or substituted with (i) one or more heteroatoms selected from N, O, S, P, and F or (ii) heteroatom groups containing one or more of said heteroatoms; (ii) contacting the deacylated substrate with a cleavage agent that cleaves the fluorophore from the structure shown in Formula (2) to release the fluorophore and generate a detectable signal having a signal intensity; and (iii) correlating said signal intensity with Sirt6, PfSir2a, or Sirt7 deacylase activity; wherein a change in Sirt6, PfSir2a, or Sirt7 deacylase activity in the presence of the candidate compound, relative to Sirt6, PfSir2a, or Sirt7 deacylase activity in the absence of the candidate compound, identifies the candidate compound as an inhibitor of Sirt6, PfSir2a, or Sirt7 deacylase activity. 2. The method of claim 1 , wherein said cleavage agent is a proteolytic enzyme. 3. The method of claim 1 , wherein said fluorophore changes its emission wavelength upon the cleavage and release of the fluorophore. 4. The method of claim 1 , wherein the candidate compound has the following chemical structure: wherein R 1 is a hydrocarbon group having at least three carbon atoms connected by carbon-carbon bonds, wherein said hydrocarbon group optionally includes one heteroatom selected from O, N, and S that interrupts a carbon-carbon bond of said hydrocarbon group or replaces a carbon atom of said hydrocarbon group, except that said heteroatom is not included as an OH, SH, or NH 2 group, and wherein one or more hydrogen atoms in said hydrocarbon group is optionally replaced with fluoro atoms; R 2 is selected from S, NR 6 , and O, wherein R 6 is a hydrogen atom or a hydrocarbon group R; X 1 , X 2 , and X 3 are independently selected from —(CH 2 ) n —, —NR 12 —, —O—, —S—, or a bond, wherein R 12 is a hydrogen atom or a hydrocarbon group R, and wherein n represents 1, 2, or 3; R 5 is a hydrogen atom or a hydrocarbon group R; R 3 and R 4 are independently hydrogen atom or a hydrocarbon group R; wherein said hydrocarbon groups R are independently either unsubstituted, or substituted with (i) one or more heteroatoms selected from N, O, S, P, and F or (ii) heteroatom groups containing one or more of said heteroatoms; wherein R 4 can alternatively be OH or SH. 5. The method of claim 4 , wherein said hydrocarbon group for R 1 has at least three carbon atoms connected by carbon-carbon bonds in the absence of heteroatom substitution, except that one or more hydrogen atoms are optionally replaced with fluoro atoms. 6. The method of claim 4 , wherein said hydrocarbon group for R 1 has at least six carbon atoms connected by carbon-carbon bonds wherein said hydrocarbon group optionally includes one heteroatom selected from O, N, and S that interrupts a carbon-carbon bond of said hydrocarbon group or replaces a carbon atom of said hydrocarbon group, except that said heteroatom is not included as an OH, SH, or NH 2 group, and wherein one or more hydrogen atoms in said hydrocarbon group is optionally replaced with fluoro atoms. 7. The method of claim 4 , wherein said hydrocarbon group for R 1 has at least seven carbon atoms connected by carbon-carbon bonds wherein said hydrocarbon group optionally includes one heteroatom selected from O, N, and S that interrupts a carbon-carbon bond of said hydrocarbon group or replaces a carbon atom of said hydrocarbon group, except that said heteroatom is not included as an OH, SH, or NH 2 group, and wherein one or more hydrogen atoms in said hydrocarbon group is optionally replaced with fluoro atoms. 8. The method of claim 4 , wherein said hydrocarbon group for R 1 has at least eight carbon atoms connected by carbon-carbon bonds wherein said hydrocarbon group optionally includes one heteroatom selected from O, N, and S that interrupts a carbon-carbon bond of said hydrocarbon group or replaces a carbon atom of said hydrocarbon group, except that said heteroatom is not included as an OH, SH, or NH 2 group, and wherein one or more hydrogen atoms in said hydrocarbon group is optionally replaced with fluoro atoms. 9. The method of claim 4 , wherein R 2 is S. 10. The method of claim 4 , wherein X 1 , X 2 , and X 3 are each —(CH 2 ) n —, wherein n is independently 1, 2, or 3. 11. The method of claim 4 , wherein R 3 and R 4 are each comprised of at least one amino acid residue. 12. The method of claim 1 , wherein R 8 in the acylated substrate is S. 13. The method of claim 1 , wherein X 4 , X 5 , and X 6 in the acylated substrate are each —(CH 2 ) n —, wherein n is independently 1, 2, or 3. 14. The method of claim 1 , wherein at least one of R 9 and R 10 in the acylated substrate is comprised of at least one amino acid residue. 15. The method of claim 1 , wherein one of R 9 and R 10 in the acylated substrate is comprised of at least one amino acid residue, and one of R 9 and R 10 is a fluorophore.
Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A) · CPC title
having 5 to 11 amino acids · CPC title
acting on amide bonds in linear amides (3.5.1) · CPC title
to hydrogen atoms or to carbon atoms of a saturated carbon skeleton · CPC title
cell-free systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.